Diagonal Bio AB (publ) (9F1.F)

0.0364 -0.0006 (-1.62%) As of 08:09AM CEST. Market open.

Diagonal Bio AB (publ)

The Spark
Medicon Village Scheelevägen 1
Lund 223 81
Sweden
46 7 35 26 27 59
https://diagonalbio.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 6

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jack Egelund Madsen	Chief Exec. Officer	N/A	N/A	N/A
Mr. Andreas Nyberg	Founder & Chief Scientific Officer	N/A	N/A	N/A
Mr. Kushagr Punyani	Tech Advisor, Founding Partner & Director	N/A	N/A	1991
Mr. Johan Kallstrand	Founding Partner	N/A	N/A	N/A
Mr. Per Heander	Chief Financial Officer	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was incorporated in 2020 and is headquartered in Lund, Sweden.

Corporate Governance

Diagonal Bio AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.